View Document Preview and Link Document Date: 2014-02-24 12:18:03 Open Document File Size: 516,50 KB Share Result on Facebook
City OTTAWA / / Company Novartis Pharmaceuticals Canada Inc. / GlaxoSmithKline Inc. / BoehringerIngelheim (Canada) Ltd. / AstraZeneca / / Country Canada / / Currency USD / / / Facility Ottawa Hospital Research Institute / / IndustryTerm age / respiratory network / healthcare resources / e-library / media representatives / care of chronic lung disease / Chronic Disease Prevention / / MedicalCondition COPD / chronic obstructive pulmonary disease / chronic lung diseases / lung cancer / lung disease / chronic lung disease / common chronic lung diseases / Respiratory Disease / asthma / / Organization CLA Board of Directors / Conference Board of Canada / Public Health Agency of Canada / Canadian Lung Association / British Columbia Lung Association / Canada's Centre for Chronic Disease Prevention and Control / Ottawa Hospital Research Institute / / Person Shawn Aaron / Debra Lynkowski / Dean Karakasis / Janis Hass / / / Position Director of Marketing and Communications / director / president and CEO / Chair / senior Scientist / director of the Canadian Research / / URL http / SocialTag 
A N EW NATIONAL RESPIRATORY NETWORK LAUNCHES Partnership invests $7.6 million to promotecutting-edge research and foster collaboration between Canada’s top experts in asthma and COPD February 24, 2014 OTTAWA — The Ca